Trial reportJournal of virology2017
HLA-B*14:02-Restricted Env-Specific CD8
Open access · hybridAbstract readClinical TrialMulticenter Study
In one paragraph
Trial report in Journal of virology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 15 citations in OpenAlex.
- Association of HLA-A, B, and C alleles and cancer susceptibility in 179 solid malignancies.American journal of translational research · 2023Article
- Vaccines against the original strain of SARS-CoV-2 provide T cell memory to the B.1.1.529 variant.Communications medicine · 2022Article
- The apparent interferon resistance of transmitted HIV-1 is possibly a consequence of enhanced replicative fitness.PLoS pathogens · 2022Article
- Immunoescape of HIV-1 in Env-EL9 CD8 + T cell response restricted by HLA-B*14:02 in a Non progressor who lost twenty-seven years of HIV-1 control.Retrovirology · 2022Article
- Low Postseroconversion CD4mBio · 2019Article
- Unusual Cysteine Content in V1 Region of gp120 From an Elite Suppressor That Produces Broadly Neutralizing Antibodies.Frontiers in immunology · 2019Article
- Differential Immunodominance Hierarchy of CD8Journal of virology · 2018Article
- Association of Diverse Genotypes and Phenotypes of Immune Cells and Immunoglobulins With the Course of HIV-1 Infection.Frontiers in immunology · 2018Review
- The influence of HLA/HIV genetics on the occurrence of elite controllers and a need for therapeutics geotargeting view.The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious DiseasesReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
23 authors at 16 institutions in 6 countries.
Ellen M LeitmanDepartment of Paediatrics, University of Oxford, Oxford, United Kingdom ellen_leitman@hms.harvard.edu.
Christian B WillbergNuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
Ming-Han TsaiDepartment of Paediatrics, University of Oxford, Oxford, United Kingdom.
Huabiao ChenRagon Institute of MGH, MIT and Harvard, Boston, Massachusetts, USA.
Søren BuusLaboratory of Experimental Immunology, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.
Fabian ChenDepartment of Sexual Health, Royal Berkshire Hospital, Reading, United Kingdom.
Lynn RiddellIntegrated Sexual Health Services, Northamptonshire Healthcare NHS Trust, Northampton, United Kingdom.
David HaasDepartments of Medicine, Pharmacology, Pathology, Microbiology, and Immunology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Jacques FellaySchool of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, Swiss Institute of Bioinformatics, Lausanne, Switzerland.
James J GoedertInfections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Alicja Piechocka-TrochaRagon Institute of MGH, MIT and Harvard, Boston, Massachusetts, USA.
Bruce D WalkerRagon Institute of MGH, MIT and Harvard, Boston, Massachusetts, USA.
Jeffrey MartinDepartment of Medicine, University of California San Francisco Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, USA.
Steven DeeksDepartment of Medicine, University of California, San Francisco, California, USA.
Steven M WolinskyNuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
Jeremy MartinsonDepartment of Infectious Diseases and Microbiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Maureen MartinCancer and Inflammation Program, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.
Ying QiCancer and Inflammation Program, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.
Asier Sáez-CiriónInstitut Pasteur, Unité HIV, Inflammation et Persistance, Paris, France.ORCID http://orcid.org/0000-0003-2406-7536
Otto O YangDepartment of Medicine, Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.
Philippa C MatthewsNuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
Mary CarringtonRagon Institute of MGH, MIT and Harvard, Boston, Massachusetts, USA.
Philip J R GoulderDepartment of Paediatrics, University of Oxford, Oxford, United Kingdom.
Leidos (United States) · USUniversity of Oxford · GBHarvard University · USRagon Institute of MGH, MIT and Harvard · USUniversity of California, San Francisco · USAIDS Healthcare Foundation · USInstitut Pasteur · FRJohn Radcliffe Hospital · GBNational Institutes of Health · USNorthamptonshire Healthcare NHS Foundation Trust · GBNorthwestern University · USRoyal Berkshire Hospital · GBSIB Swiss Institute of Bioinformatics · CHUniversity of Copenhagen · DKUniversity of Pittsburgh · USVanderbilt University · US
Funding
Virology CoreP30AI027763 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MALLORY O JOHNSON · 1988 to 2026
$93.6MNATURAL HISTORY OF AIDS IN HOMOSEXUAL MENU01AI035040 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DETELS, ROGER, MARTINEZ-MAZA, OTONIEL · 1993 to 2018
$75.2MUniversity of Pittsburgh Multicenter AIDS Cohort Study (MACS)U01AI035041 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MARTINSON, JEREMY JAMES, RINALDO, CHARLES R · 1993 to 2018
$71.4MMULTICENTER AIDS COHORT STUDYU01AI035039 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI WOLINSKY, STEVEN M · 1993 to 2018
$66.4MMulticenter Aids Cohort Study- Part B (Baltimore Site)U01AI035042 · NIAID · JOHNS HOPKINS UNIVERSITY · PI BROWN, TODD T, MARGOLICK, JOSEPH B. · 1993 to 2018
$61.5MCenter for the Analysis & Management of the Multicenter AIDS Cohort StudyUM1AI035043 · NIAID · JOHNS HOPKINS UNIVERSITY · PI D'SOUZA, GYPSYAMBER, JACOBSON, LISA P · 2012 to 2018
$20.7MPharmacogenomics of HIV TherapyR01AI077505 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI HAAS, DAVID W · 2008 to 2025
$12.3MOptimizing CD8+ T-cell responses against C clade HIV infection in subSaharan AfriR01AI046995 · NIAID · UNIVERSITY OF OXFORD · PI GOULDER, PHILIP J · 2000 to 2014
$6.8MCCR NIH HHS HHSN261200800001CNCI NIH HHS HHSN261200800001ENIAID NIH HHS P30 AI027763NIAID NIH HHS R01 AI046995NIAID NIH HHS R01 AI077505NIAID NIH HHS U01 AI035039NIAID NIH HHS U01 AI035040NIAID NIH HHS U01 AI035041NIAID NIH HHS U01 AI035042NIAID NIH HHS UM1 AI035043Wellcome Trust
Abstract
Immune control of human immunodeficiency virus type 1 (HIV) infection is typically associated with effective Gag-specific CD8
Indexed as
Immunity, CellularAdultCD8-Positive T-Lymphocytesgag Gene Products, Human Immunodeficiency VirusHIV-1HIV Envelope Protein gp160HIV InfectionsHLA-B14 AntigenHumansPeptidesgag Gene Products, Human Immunodeficiency VirusHIV Envelope Protein gp160HLA-B*14:01 antigenHLA-B*14:02 antigenHLA-B14 AntigenPeptidesCD8+ T cellsHIVHLA-B*14immune control
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.